This menu provides the list of EV proteins identified by high-throughput analyses.

Search:
Superdomain: All Prokaryote Eukaryote
Filter datasets:
  - "Sample type" indicates the source from which EVs originated (e.g. B cell, serum).
  - "Sample status" indicates the condition of the source from which EVs originated (e.g. Normal, miR-146a-treated, Patients of hernia).
Number of molecules in one page:

The downloaded CSV file is not exactly the same as the displayed table. Opening CSV file with Excel can impair its content.

Protein name UniProt accession Publication Orthologous group Identification count
All / Prokaryote / Eukaryote
Lysosomal acid phosphatase (LAP) (EC 3.1.3.2)P11117Identification and proteomic profiling of exosomes in human urine.
Proc Natl Acad Sci U S A. 2004 Sep 7;101(36):13368-73. Epub 2004 Aug 23.
ENOG410ZVBQ106 / 0 / 106
Lysosomal acid phosphatase (LAP) (EC 3.1.3.2)P11117Comparative proteomic analysis of PAI-1 and TNF-alpha-derived endothelial microparticles.
Proteomics. 2008 Jun;8(12):2430-46. doi: 10.1002/pmic.200701029.
ENOG410ZVBQ106 / 0 / 106
Lysosomal acid phosphatase (LAP) (EC 3.1.3.2)P11117Large-scale proteomics and phosphoproteomics of urinary exosomes.
J Am Soc Nephrol. 2009 Feb;20(2):363-79. doi: 10.1681/ASN.2008040406. Epub 2008 Dec 3.
ENOG410ZVBQ106 / 0 / 106
Lysosomal acid phosphatase (LAP) (EC 3.1.3.2)P11117Proteomic analysis of urine exosomes by multidimensional protein identification technology (MudPIT).
Proteomics. 2012 Jan;12(2):329-38. doi: 10.1002/pmic.201100477. Epub 2011 Dec 16.
ENOG410ZVBQ106 / 0 / 106
Lysosomal acid phosphatase (LAP) (EC 3.1.3.2)P11117A multiplex quantitative proteomics strategy for protein biomarker studies in urinary exosomes.
Kidney Int. 2012 Jun;81(12):1263-72. doi: 10.1038/ki.2012.25. Epub 2012 Mar 14.
ENOG410ZVBQ106 / 0 / 106
Lysosomal acid phosphatase (LAP) (EC 3.1.3.2)P11117Proteomic analysis of microvesicles from plasma of healthy donors reveals high individual variability.
J Proteomics. 2012 Jun 27;75(12):3574-84. doi: 10.1016/j.jprot.2012.03.054. Epub 2012 Apr 10.
ENOG410ZVBQ106 / 0 / 106
Lysosomal acid phosphatase (LAP) (EC 3.1.3.2)P11117Proteomic analysis of microvesicles from plasma of healthy donors reveals high individual variability.
J Proteomics. 2012 Jun 27;75(12):3574-84. doi: 10.1016/j.jprot.2012.03.054. Epub 2012 Apr 10.
ENOG410ZVBQ106 / 0 / 106
Lysosomal acid phosphatase (LAP) (EC 3.1.3.2)P11117Proteomic analysis of microvesicles from plasma of healthy donors reveals high individual variability.
J Proteomics. 2012 Jun 27;75(12):3574-84. doi: 10.1016/j.jprot.2012.03.054. Epub 2012 Apr 10.
ENOG410ZVBQ106 / 0 / 106
Lysosomal acid phosphatase (LAP) (EC 3.1.3.2)P11117Biochemical and physical characterisation of urinary nanovesicles following CHAPS treatment.
PLoS One. 2012;7(7):e37279. doi: 10.1371/journal.pone.0037279. Epub 2012 Jul 12.
ENOG410ZVBQ106 / 0 / 106
Lysosomal acid phosphatase (LAP) (EC 3.1.3.2)P11117Biochemical and physical characterisation of urinary nanovesicles following CHAPS treatment.
PLoS One. 2012;7(7):e37279. doi: 10.1371/journal.pone.0037279. Epub 2012 Jul 12.
ENOG410ZVBQ106 / 0 / 106
Lysosomal acid phosphatase (LAP) (EC 3.1.3.2)P11117Comparative and targeted proteomic analyses of urinary microparticles from bladder cancer and hernia patients.
J Proteome Res. 2012 Dec 7;11(12):5611-29. doi: 10.1021/pr3008732. Epub 2012 Oct 31.
ENOG410ZVBQ106 / 0 / 106
Lysosomal acid phosphatase (LAP) (EC 3.1.3.2)P11117Comparative and targeted proteomic analyses of urinary microparticles from bladder cancer and hernia patients.
J Proteome Res. 2012 Dec 7;11(12):5611-29. doi: 10.1021/pr3008732. Epub 2012 Oct 31.
ENOG410ZVBQ106 / 0 / 106
Lysosomal acid phosphatase (LAP) (EC 3.1.3.2)P11117Characterization and proteomic analysis of ovarian cancer-derived exosomes.
J Proteomics. 2013 Jan 16;80C:171-182. doi: 10.1016/j.jprot.2012.12.029.
ENOG410ZVBQ106 / 0 / 106
Lysosomal acid phosphatase (LAP) (EC 3.1.3.2)P11117Characterization and proteomic analysis of ovarian cancer-derived exosomes.
J Proteomics. 2013 Jan 16;80C:171-182. doi: 10.1016/j.jprot.2012.12.029.
ENOG410ZVBQ106 / 0 / 106
Lysosomal acid phosphatase (LAP) (EC 3.1.3.2)P11117Proteomic analysis of podocyte exosome-enriched fraction from normal human urine.
J Proteomics. 2013 Apr 26;82:193-229. doi: 10.1016/j.jprot.2013.01.012. Epub 2013 Jan 30.
ENOG410ZVBQ106 / 0 / 106
Lysosomal acid phosphatase (LAP) (EC 3.1.3.2)P11117Differential protein profiling of renal cell carcinoma urinary exosomes.
Mol Biosyst. 2013 Jun;9(6):1220-33. doi: 10.1039/c3mb25582d. Epub 2013 Mar 19.
ENOG410ZVBQ106 / 0 / 106
Lysosomal acid phosphatase (LAP) (EC 3.1.3.2)P11117In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine.
Proteomics. 2013 May;13(10-11):1667-71. doi: 10.1002/pmic.201200561. Epub 2013 Apr 23.
ENOG410ZVBQ106 / 0 / 106
Lysosomal acid phosphatase (LAP) (EC 3.1.3.2)P11117In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine.
Proteomics. 2013 May;13(10-11):1667-71. doi: 10.1002/pmic.201200561. Epub 2013 Apr 23.
ENOG410ZVBQ106 / 0 / 106
Lysosomal acid phosphatase (LAP) (EC 3.1.3.2)P11117A novel role for pro-coagulant microvesicles in the early host defense against streptococcus pyogenes.
PLoS Pathog. 2013;9(8):e1003529. doi: 10.1371/journal.ppat.1003529. Epub 2013 Aug 1.
ENOG410ZVBQ106 / 0 / 106
Lysosomal acid phosphatase (LAP) (EC 3.1.3.2)P11117A novel role for pro-coagulant microvesicles in the early host defense against streptococcus pyogenes.
PLoS Pathog. 2013;9(8):e1003529. doi: 10.1371/journal.ppat.1003529. Epub 2013 Aug 1.
ENOG410ZVBQ106 / 0 / 106
Lysosomal acid phosphatase (LAP) (EC 3.1.3.2)P11117Exosomal ITGA3 interferes with non-cancerous prostate cell functions and is increased in urine exosomes of metastatic prostate cancer patients.
J Extracell Vesicles. 2013 Dec 23;2. doi: 10.3402/jev.v2i0.22097. eCollection 2013.
ENOG410ZVBQ106 / 0 / 106
Lysosomal acid phosphatase (LAP) (EC 3.1.3.2)P11117In-depth proteomic analyses of ovarian cancer cell line exosomes reveals differential enrichment of functional categories compared to the NCI 60 proteome.
Biochem Biophys Res Commun. 2014 Mar 21;445(4):694-701. doi: 10.1016/j.bbrc.2013.12.070. Epub 2014 Jan 14.
ENOG410ZVBQ106 / 0 / 106
Lysosomal acid phosphatase (LAP) (EC 3.1.3.2)P11117Proteomic analysis of cerebrospinal fluid extracellular vesicles: a comprehensive dataset.
J Proteomics. 2014 Jun 25;106:191-204. doi: 10.1016/j.jprot.2014.04.028. Epub 2014 Apr 24.
ENOG410ZVBQ106 / 0 / 106
Lysosomal acid phosphatase (LAP) (EC 3.1.3.2)P11117A New Workflow for Proteomic Analysis of Urinary Exosomes and Assessment in Cystinuria Patients.
J Proteome Res. 2014 Nov 12.
ENOG410ZVBQ106 / 0 / 106
Lysosomal acid phosphatase (LAP) (EC 3.1.3.2)P11117A New Workflow for Proteomic Analysis of Urinary Exosomes and Assessment in Cystinuria Patients.
J Proteome Res. 2014 Nov 12.
ENOG410ZVBQ106 / 0 / 106
Lysosomal acid phosphatase (LAP) (EC 3.1.3.2)P11117Intraluminal proteome and peptidome of human urinary extracellular vesicles.
Proteomics Clin Appl. 2014 Dec 4. doi: 10.1002/prca.201400085.
ENOG410ZVBQ106 / 0 / 106
Lysosomal acid phosphatase (LAP) (EC 3.1.3.2)P11117Perturbations in the urinary exosome in transplant rejection.
Front Med (Lausanne). 2015 Jan 5;1:57. doi: 10.3389/fmed.2014.00057. eCollection 2014.
ENOG410ZVBQ106 / 0 / 106
Lysosomal acid phosphatase (LAP) (EC 3.1.3.2)P11117Microparticles released from Mycobacterium tuberculosis-infected human macrophages contain increased levels of the type I interferon inducible proteins including ISG15.
Proteomics. 2015 Jun 2. doi: 10.1002/pmic.201400610.
ENOG410ZVBQ106 / 0 / 106
Lysosomal acid phosphatase (LAP) (EC 3.1.3.2)P11117Microparticles released from Mycobacterium tuberculosis-infected human macrophages contain increased levels of the type I interferon inducible proteins including ISG15.
Proteomics. 2015 Jun 2. doi: 10.1002/pmic.201400610.
ENOG410ZVBQ106 / 0 / 106
Lysosomal acid phosphatase (LAP) (EC 3.1.3.2)P11117Increased expression of lysosome membrane protein 2 in glomeruli of patients with idiopathic membranous nephropathy.
Proteomics. 2015 Aug 24. doi: 10.1002/pmic.201500127.
ENOG410ZVBQ106 / 0 / 106
Lysosomal acid phosphatase (LAP) (EC 3.1.3.2)P11117Increased expression of lysosome membrane protein 2 in glomeruli of patients with idiopathic membranous nephropathy.
Proteomics. 2015 Aug 24. doi: 10.1002/pmic.201500127.
ENOG410ZVBQ106 / 0 / 106
Lysosomal acid phosphatase (LAP) (EC 3.1.3.2)P11117Increased expression of lysosome membrane protein 2 in glomeruli of patients with idiopathic membranous nephropathy.
Proteomics. 2015 Aug 24. doi: 10.1002/pmic.201500127.
ENOG410ZVBQ106 / 0 / 106
Lysosomal acid phosphatase (LAP) (EC 3.1.3.2)P11117Exosomes mediated pentose phosphate pathway in ovarian cancer metastasis: a proteomics analysis.
Int J Clin Exp Pathol. 2015 Dec 1;8(12):15719-28. eCollection 2015.
ENOG410ZVBQ106 / 0 / 106
Lysosomal acid phosphatase (LAP) (EC 3.1.3.2)P11117Effective isolation of exosomes with polyethylene glycol from cell culture supernatant for in-depth proteome profiling.
Analyst. 2016 May 27.
ENOG410ZVBQ106 / 0 / 106
Lysosomal acid phosphatase (LAP) (EC 3.1.3.2)P11117Proteomic Analysis of Exosomes and Exosome-Free Conditioned Media Derived from Human Osteosarcoma Cell Lines Reveal Differential Secretion of Proteins Related to Biological Functions and Tumor Progression.
J Cell Biochem. 2016 Jun 30. doi: 10.1002/jcb.25642.
ENOG410ZVBQ106 / 0 / 106
Lysosomal acid phosphatase (LAP) (EC 3.1.3.2)P11117Efficient production and enhanced tumor delivery of engineered extracellular vesicles.
Biomaterials. 2016 Jul 6;105:195-205. doi: 10.1016/j.biomaterials.2016.07.003.
ENOG410ZVBQ106 / 0 / 106
Lysosomal acid phosphatase (LAP) (EC 3.1.3.2)P11117Identification and Characterization of 293T Cell-Derived Exosomes by Profiling the Protein, mRNA and MicroRNA Components.
PLoS One. 2016 Sep 20;11(9):e0163043. doi: 10.1371/journal.pone.0163043. eCollection 2016.
ENOG410ZVBQ106 / 0 / 106
Lysosomal acid phosphatase (LAP) (EC 3.1.3.2)P11117Extracellular vesicles as a source for non-invasive biomarkers in bladder cancer progression.
Eur J Pharm Sci. 2016 Oct 14. pii: S0928-0987(16)30431-6. doi: 10.1016/j.ejps.2016.10.008.
ENOG410ZVBQ106 / 0 / 106
Lysosomal acid phosphatase (LAP) (EC 3.1.3.2)P11117Extracellular vesicles as a source for non-invasive biomarkers in bladder cancer progression.
Eur J Pharm Sci. 2016 Oct 14. pii: S0928-0987(16)30431-6. doi: 10.1016/j.ejps.2016.10.008.
ENOG410ZVBQ106 / 0 / 106
Lysosomal acid phosphatase (LAP) (EC 3.1.3.2)P11117High-resolution proteomic and lipidomic analysis of exosomes and microvesicles from different cell sources.
J Extracell Vesicles. 2016 Nov 17;5:32570. doi: 10.3402/jev.v5.32570. eCollection 2016.
ENOG410ZVBQ106 / 0 / 106
Lysosomal acid phosphatase (LAP) (EC 3.1.3.2)P11117Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG410ZVBQ106 / 0 / 106
Lysosomal acid phosphatase (LAP) (EC 3.1.3.2)P11117Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG410ZVBQ106 / 0 / 106
Lysosomal acid phosphatase (LAP) (EC 3.1.3.2)P11117Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG410ZVBQ106 / 0 / 106
Lysosomal acid phosphatase (LAP) (EC 3.1.3.2)P11117Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG410ZVBQ106 / 0 / 106
Lysosomal acid phosphatase (LAP) (EC 3.1.3.2)P11117Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG410ZVBQ106 / 0 / 106
Lysosomal acid phosphatase (LAP) (EC 3.1.3.2)P11117Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG410ZVBQ106 / 0 / 106
Lysosomal acid phosphatase (LAP) (EC 3.1.3.2)P11117Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG410ZVBQ106 / 0 / 106
Lysosomal acid phosphatase (LAP) (EC 3.1.3.2)P11117Proteomic analysis of urinary extracellular vesicles from high Gleason score prostate cancer.
Sci Rep. 2017 Feb 17;7:42961. doi: 10.1038/srep42961.
ENOG410ZVBQ106 / 0 / 106
Lysosomal acid phosphatase (LAP) (EC 3.1.3.2)P11117Proteomic analysis of urinary extracellular vesicles from high Gleason score prostate cancer.
Sci Rep. 2017 Feb 17;7:42961. doi: 10.1038/srep42961.
ENOG410ZVBQ106 / 0 / 106
Lysosomal acid phosphatase (LAP) (EC 3.1.3.2)P11117Proteomic analysis of urinary extracellular vesicles from high Gleason score prostate cancer.
Sci Rep. 2017 Feb 17;7:42961. doi: 10.1038/srep42961.
ENOG410ZVBQ106 / 0 / 106
Lysosomal acid phosphatase (LAP) (EC 3.1.3.2)P11117Characterisation of extracellular vesicle-subsets derived from brain endothelial cells and analysis of their protein cargo modulation after TNF exposure.
J Extracell Vesicles. 2017 Apr 19;6(1):1302705. doi: 10.1080/20013078.2017.1302705. eCollection 2017.
ENOG410ZVBQ106 / 0 / 106
Lysosomal acid phosphatase (LAP) (EC 3.1.3.2)P11117Urinary exosomes reveal protein signatures in hypertensive patients with albuminuria.
Oncotarget. 2017 May 11. doi: 10.18632/oncotarget.17787.
ENOG410ZVBQ106 / 0 / 106
Lysosomal acid phosphatase (LAP) (EC 3.1.3.2)P11117Small extracellular vesicles secreted from senescent cells promote cancer cell proliferation through EphA2.
Nat Commun. 2017 Jun 6;8:15729. doi: 10.1038/ncomms15728.
ENOG410ZVBQ106 / 0 / 106
Lysosomal acid phosphatase (LAP) (EC 3.1.3.2)P11117Feasibility of urinary extracellular vesicle proteome profiling using a robust and simple, clinically applicable isolation method.
J Extracell Vesicles. 2017 Apr 28;6(1):1313091. doi: 10.1080/20013078.2017.1313091. eCollection 2017.
ENOG410ZVBQ106 / 0 / 106
Lysosomal acid phosphatase (LAP) (EC 3.1.3.2)P11117Feasibility of urinary extracellular vesicle proteome profiling using a robust and simple, clinically applicable isolation method.
J Extracell Vesicles. 2017 Apr 28;6(1):1313091. doi: 10.1080/20013078.2017.1313091. eCollection 2017.
ENOG410ZVBQ106 / 0 / 106
Lysosomal acid phosphatase (LAP) (EC 3.1.3.2)P11117Feasibility of urinary extracellular vesicle proteome profiling using a robust and simple, clinically applicable isolation method.
J Extracell Vesicles. 2017 Apr 28;6(1):1313091. doi: 10.1080/20013078.2017.1313091. eCollection 2017.
ENOG410ZVBQ106 / 0 / 106
Lysosomal acid phosphatase (LAP) (EC 3.1.3.2)P11117Proteomic analysis of neuroblastoma-derived exosomes: new insights into a metastatic signature.
Proteomics. 2017 Jul 19. doi: 10.1002/pmic.201600430.
ENOG410ZVBQ106 / 0 / 106
Lysosomal acid phosphatase (LAP) (EC 3.1.3.2)P11117Proteomic analysis of neuroblastoma-derived exosomes: new insights into a metastatic signature.
Proteomics. 2017 Jul 19. doi: 10.1002/pmic.201600430.
ENOG410ZVBQ106 / 0 / 106
Lysosomal acid phosphatase (LAP) (EC 3.1.3.2)P11117Proteomic analysis of neuroblastoma-derived exosomes: new insights into a metastatic signature.
Proteomics. 2017 Jul 19. doi: 10.1002/pmic.201600430.
ENOG410ZVBQ106 / 0 / 106
Lysosomal acid phosphatase (LAP) (EC 3.1.3.2)P11117Proteomic analysis of neuroblastoma-derived exosomes: new insights into a metastatic signature.
Proteomics. 2017 Jul 19. doi: 10.1002/pmic.201600430.
ENOG410ZVBQ106 / 0 / 106
Lysosomal acid phosphatase (LAP) (EC 3.1.3.2)P11117Quantitation of putative colorectal cancer biomarker candidates in serum extracellular vesicles by targeted proteomics.
Sci Rep. 2017 Oct 6;7(1):12782. doi: 10.1038/s41598-017-13092-x.
ENOG410ZVBQ106 / 0 / 106
Lysosomal acid phosphatase (LAP) (EC 3.1.3.2)P11117Surfaceome profiling enables isolation of cancer-specific exosomal cargo in liquid biopsies from pancreatic cancer patients.
Ann Oncol. 2017 Sep 25. doi: 10.1093/annonc/mdx542.
ENOG410ZVBQ106 / 0 / 106
Lysosomal acid phosphatase (LAP) (EC 3.1.3.2)P11117Surfaceome profiling enables isolation of cancer-specific exosomal cargo in liquid biopsies from pancreatic cancer patients.
Ann Oncol. 2017 Sep 25. doi: 10.1093/annonc/mdx542.
ENOG410ZVBQ106 / 0 / 106
Lysosomal acid phosphatase (LAP) (EC 3.1.3.2)P11117Hepatic stellate cell-derived PDGFRalpha-enriched extracellular vesicles promote liver fibrosis in mice through SHP2.
Hepatology. 2018 Jan 23. doi: 10.1002/hep.29803.
ENOG410ZVBQ106 / 0 / 106
Lysosomal acid phosphatase (LAP) (EC 3.1.3.2)P11117Hepatic stellate cell-derived PDGFRalpha-enriched extracellular vesicles promote liver fibrosis in mice through SHP2.
Hepatology. 2018 Jan 23. doi: 10.1002/hep.29803.
ENOG410ZVBQ106 / 0 / 106
Lysosomal acid phosphatase (LAP) (EC 3.1.3.2)P11117Hepatic stellate cell-derived PDGFRalpha-enriched extracellular vesicles promote liver fibrosis in mice through SHP2.
Hepatology. 2018 Jan 23. doi: 10.1002/hep.29803.
ENOG410ZVBQ106 / 0 / 106
[1]